Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Apr 9, 2008

Intradigm Licenses siRNA IP from UMass Medical

  • Intradigm has licensed intellectual property covering certain efficacy-enhancing structural elements of siRNA from the University of Massachusetts Medical School.

    The licensed technology will allow Intradigm to incorporate novel siRNA sequences into its RNAi delivery systems. This IP includes parameters for the structural modifications for siRNAs including the Zamore Design Rules that improve the potency and efficacy of RNAi therapeutics, according to the company.



Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »